Skip to main content

Xeris Biopharma Holdings, Inc.

XERS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001867096

In the last 90 days, Xeris Biopharma Holdings, Inc. insiders filed 0 open-market purchases and 11 sales; 242 institutions reported holding it in 13F filings for Q2 2026, worth $857.1M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Xeris Biopharma Holdings, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of XERS: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders103101−2
Shares59.3M57.3M−2.04M (−3.4%)
Value$91.3M$89.3M−$1.98M (−2.2%)

New holders (9)

Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to XERS in Q3 2022
InstitutionSharesValue% of portfolio
Kamunting Street Capital Management, L.P.75,000$117.0K0.21%
Bailard, Inc.56,000$87.0K0.00%
Mariner, LLC30,300$47.0K0.00%
SG Americas Securities, LLC25,397$40.0K0.00%
AQR Capital Management LLC20,542$32.0K0.00%
Arkadios Wealth Advisors11,000$17.0K0.00%
Massmutual Trust Co FSB986$2.00K0.00%
Point72 Hong Kong Ltd1,558$2.00K0.00%
China Universal Asset Management Co., Ltd.1,273$2.00K0.00%

Sold out (11)

Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of XERS in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Millennium Management LLC552,549$851.0K
Qube Research & Technologies Ltd196,528$303.0K
AE Wealth Management LLC79,787$123.0K
Dimensional Fund Advisors LP45,082$69.0K
Rafferty Asset Management, LLC35,248$54.0K
Veritable, L.P.32,174$50.0K
Laurion Capital Management LP20,756$32.0K
Squarepoint Ops LLC11,651$18.0K
Simplex Trading, LLC4,056$6.00K
Investment Research & Advisory Group, Inc.803$1.00K
Bank of Montreal103$0